Imunon, Inc. (IMNN): EPS (Diluted)
-$6.83
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.83 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$16.94 | n/c | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$2.16 | n/m | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | -$5.03 | n/a | 2024-03-28, From 2022-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | -$6.83 | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$0.12 | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | -$0.25 | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$7.47 | n/m |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$1.26 | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | -$23.95 | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | -$0.17 | n/m |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $2.16 | -11.1% |
| MetaVia Inc. (MTVA) | 2025-12-31 | -$7.35 | n/m |
Compare IMNN, TTRX, ANEB, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗